Improving cervical cancer screening and treatment for women with HIV in Kenya
Official title: ENHANcing CErvical cancer screening and treatment in women LIviNg with HIV in KenyA (ENHANCE LINKAge)
Funded at Emory University · NIH-11406365 · Data updated 2026-11-12
This project works to make cervical cancer screening, follow-up, and treatment easier and more reliable for women living with HIV in Kenya.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $105,527 |
| NIH project number | 3U01CA275120-02S2 |
| Project ID | NIH-11406365 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women living with HIV who receive care at participating public HIV clinics in Kenya and who need cervical cancer screening or follow-up are ideal candidates.
✕Less likely to help
People who do not live in Kenya, men, or women without HIV are unlikely to benefit directly from this project.
What this research studies
If you are a woman living with HIV in Kenya, the team will work inside HIV clinics to make HPV and cervical cancer screening more dependable and to close gaps that stop people from getting care. They will try practical solutions like better screening methods, clearer referral pathways, staff training, and systems to track and remind patients who need follow-up tests or treatment. The project will collect information on what helps and share findings to improve clinic services and accountability over time.
Why it matters
Potential benefit: If successful, more women with HIV could get timely screening and treatment, lowering the number of advanced cervical cancers and deaths.
How similar studies have gone: Previous programs have added screening into HIV clinics but often failed to link women to treatment, so this project applies new implementation approaches to address those persistent gaps.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
Related research
Other NIH-funded projects on the same topics.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
HOPE-inG: Increasing cervical cancer screening for women with HIV in Ghana
A study tests a home-based HPV self-sampling approach plus a tailored communication plan to help women living with HIV in Ghana get screened more often for cervical cancer.
-
CODA-based cervical cancer screening for LMICs using CRISPR and fluorescence
A low-resource, rapid test called CODA uses CRISPR and light signals to detect cervical cancer markers in women in sub-Saharan Africa to improve screening.
-
CODA-based cervical cancer screening in low-resource settings
A new, quick, low-cost test using CRISPR and fluorescence readouts to help screen for cervical cancer in women in sub-Saharan Africa.
-
CATSystem: a digital tool to boost cervical cancer screening and follow-up in Kenya
A digital tracking system helps doctors and patients in Kenya improve cervical cancer screening, treatment referrals, and follow-up, especially for women living with HIV.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.